|
|
Article: Clinical Data, Inc. Prices Public Offering of Common Stock.
- Article from:
- Investment Weekly News
- Article date:
- November 14, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Clinical Data, Inc. (NASDAQ: CLDA) announced that it has raised gross proceeds of approximately $47.4 million through the public offering of 2,750,000 newly issued shares of its common stock at a price of $17.25 per share. All of the shares are being offered by Clinical Data, Inc. The underwriters have an option to purchase up to an additional 412,500 shares to cover over-allotments, which, if purchased, would result in total gross proceeds to the Company of approximately $54.6 million. The offering is expected to close no later than November 2, 2009, subject to the satisfaction of customary closing conditions.
Piper Jaffray & Co. is acting as the sole book ...
Related newspaper, magazine, and journal articles:
|
|
Article: Clinical Data Completes Acquisition of Avalon ...
Mergers & Acquisitions Business;
June 17, 2009 ;
700+ words
... ... 0470 of a share of Clinical Data common stock and a contingent value ... additional 0.01175 shares of Clinical Data common stock based on payments received ... 00940 of a share of Clinical Data common stock, payable after June ...
|
|